Jung-Woo Ma, MD
Pain Medicine · Concord, NHNPI 1073771515
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.7% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,267 and has fallen 61.7% since, to $485 in 2025.
Across 139 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$485
- Boston Scientific$309
- Daiichi Sankyo Inc.$215
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$166
- Tersera Therapeutics LLC$148
- Davol Inc.$147
- plus $1K from 27 others
What the payments were for
- Travel & lodging$2549%
- Food & beverage$2,47691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SPR Therapeutics, Inc | 2 | $485 |
| Boston Scientific | 16 | $309 |
| Daiichi Sankyo Inc. | 19 | $215 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $166 |
| Tersera Therapeutics LLC | 8 | $148 |
| Davol Inc. | 1 | $147 |
| Teva Pharmaceuticals USA, Inc. | 11 | $146 |
| Nevro Corp. | 3 | $127 |
| Scilex Pharmaceuticals Inc. | 8 | $112 |
| Redhill Biopharma Inc. | 5 | $92 |
| Sentynl Therapeutics, Inc. | 5 | $87 |
| Collegium Pharmaceutical, Inc. | 6 | $81 |
| Abbott | 4 | $78 |
| Biodelivery Sciences International, Inc. | 5 | $62 |
| AbbVie | 3 | $48 |
| MDD US Operations, LLC | 3 | $46 |
| Vertical Pharmaceuticals, LLC | 3 | $45 |
| Pfizer | 3 | $39 |
| Bioventus LLC | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Mallinckrodt Enterprises LLC | 1 | $27 |
| Novartis | 2 | $25 |
| Pacira Therapeutics, Inc. | 1 | $24 |
| GRT US Holding, Inc. | 1 | $22 |
| Shionogi Inc | 1 | $19 |
| Flowonix Medical Incorporated | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Si-bone, Inc. | 1 | $16 |
| Assertio Therapeutics, Inc. | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Amgen | 1 | $13 |
| Tanabe Pharma America, Inc. | 1 | $13 |
| Medtronic | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$485
- PROGEL$147
- SPECTRA WAVEWRITER$109
How this compares
$2,730 in reported general payments places this provider in the 60th percentile of 38 pain medicine providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 118 | $4,423 |
| Gabapentin | 213 | $2,915 |
| Duloxetine Hcl | 81 | $847 |
| Tizanidine Hcl | 63 | $440 |
| Diazepam | 174 | $204 |
| Meloxicam | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Concord
- Nita GroverConcord$3K
- Jeremy CollinsConcord$748
- Robert SpencerConcord$116
- Praveen SuchdevNashua$72K
- Zubin BatlivalaBedford$18K
- Bert FichmanLebanon$15K
- Dennis ThapaDover$13K
- Michael BovaLebanon$12K
- James MirazitaNashua$10K
- Robert LehnPortsmouth$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.